AMRN
Amarin Corp PlcstockNASDAQADR
At CloseNov 13, 2026 3:59:52 PM EST
11.44USD-1.971%(-0.23)36,787
After-hoursNov 13, 2026 4:00:30 PM EST
11.38USD-0.524%(-0.06)
Loading…
Loading…
480.54M
Healthcare
Drug Manufacturers-General
CEO
John Thero
HQ
Dublin, Shelbourne Road Ballsbridge, Ireland
365
Previous Close
$11.67
Beta
0.50
52-Week High
$17.31 2026-01-23
52-Week Low
$11.25 2026-10-22
SMA 50
$12.58
SMA 200
$14.15
Avg. Vol 10D
93,739
Avg. Vol 30D
78,824
Avg. Vol 90D
69,678
Relative Vol
0.47
42.04M
20.89M
49.70%
537,876
2.57%
7.58
54%/46%
56.33%
30.61%
0.3800%
1,000,000
1
Apr 11, 2025 · 1-for-20 (reverse)
176.1M
-19.1M
-0.05
-18.19
-4.24
Nov 11, 2026
Amarin: 3 Key Takeaways for Long-Term Investors ·
The Motley Fool+1 source
Nov 9, 2026
Amarin presents cardiovascular research data at AHA meeting ·
Investing.com
Oct 28, 2026
Amarin Corporation plc (AMRN) Q3 2026 Earnings Call Transcript ·
Seeking Alpha
AMRN Profile
amarin corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. amarin's product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. vascepa® (icosapent ethyl) is amarin's first fda approved product and is available in the united states by prescription. for more information about vascepa visit www.vascepa.com.
AMRN Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 11.61 | 2026-11-06 | -1.55% | 0.352 |
| 1M | 11.58 | 2026-10-13 | -1.29% | 1.094 |
| 3M | 14.15 | 2026-08-13 | -19.22% | 0.678 |
| 6M | 15.02 | 2026-05-13 | -23.90% | 0.416 |
| 1Y | 16.27 | 2025-11-13 | -29.75% | 0.498 |
| 2Y | 11.39 | 2024-11-13 | +0.35% | — |
| 5Y | 81.20 | 2021-11-12 | -85.92% | 1.084 |
AMRN Stock Summary
Amarin Corp Plc (NASDAQ:AMRN) stock price today is $11.43, and today's volume is 36,787. AMRN is down 2.057% today. The 30 day average volume is 78,824. AMRN market cap is $480.54M with 42.04M shares outstanding.
